JonathanHaynesEsenstenMD

Pathology • San Francisco, CA

Blood Banking & Transfusion Medicine, Transplantation Immunology, Clinical Pathology

Physician

Join to view full profile

Are you Dr. Esensten?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 12 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
185 Berry St Ste 100
C/O Kirsten Dahmen
San Francisco, CA 94107
Phone+1 415-353-7359

Fax+1 415-514-8928
Is this information wrong?

Summary

Dr. Jonathan Esensten, MD is a board certified pathologist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with Zuckerberg San Francisco General Hospital and Trauma Center and UCSF Medical Center.

Education & Training

University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 2012 - 2015
University of California San Francisco School of MedicineClass of 2012

Certifications & Licensure

CA State Medical License 2014 - 2025
American Board of Pathology Pathology - Clinical
American Board of Pathology Blood Banking/Transfusion Medicine

Publications & Presentations

PubMed

11 citations
Polyclonal Regulatory T Cell Manufacturing Under cGMP: A Decade of Experience
Joanna Balcerek, Brian R. Shy, Amy L. Putnam, Lisa M. Masiello, Angela P. Lares, Florinna Dekovic, Luis A. Acevedo, Michael R. Lee, Vinh Son Nguyen, Weihong Liu, Sreen...> ;Frontiers in Immunology. 2021 Nov 18
3 citations
Characteristics of High-Titer Convalescent Plasma and Antibody Dynamics After Administration in Patients With Severe Coronavirus Disease 2019
E. Bainbridge, Priscilla Y. Hsue, Jonathan H. Esensten, Kara L. Lynch, Carolyn M. Hendrickson, Sarah B Doernberg, Monica Fung, Peter Chin-Hong, Clara Di Germanio, Phil...> ;Open Forum Infectious Diseases. 2021 Jul 16
78 citations
The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes.
Shen Dong, Kamir J Hiam-Galvez, Cody T. Mowery, Kevan C. Herold, Stephen E. Gitelman, Jonathan H. Esensten, Weihong Liu, Angela P. Lares, Ashley S. Leinbach, Michael R...> ;JCI Insight. 2021 Sep 22
18 citations
Outcomes after ultramassive transfusion in the modern era: An Eastern Association for the Surgery of Trauma multicenter study
Zachary A. Matthay, Zane J. Hellmann, Rachael A. Callcut, Ellicott C. Matthay, Brenda Nunez-Garcia, William Q. Duong, Jeffry Nahmias, Aimee K. Lariccia, M Chance Spald...> ;The Journal of Trauma and Acute Care Surgery. 2021 Jul 1
2 citations
Processing laboratory considerations for multi-center cellular therapy clinical trials: a report from the Consortium for Pediatric Cellular Immunotherapy.
Catherine Lindgren, Ashley S. Leinbach, Julie Annis, Jay Tanna, Nan Zhang, Jonathan H. Esensten, Patrick J. Hanley> ;Cytotherapy. 2021 Feb 1
Magnitude and Kinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Responses and Their Relationship to Disease Severity.
Kara L Lynch, Jeffrey D Whitman, Noreen P Lacanienta, Erica W Beckerdite, Shannon A Kastner, Brian R Shy, Gregory M Goldgof, Andrew G Levine, Sagar P Bapat, Susan L St...> ;Clinical Infectious Diseases. 2021 Jan 27
Hospital-Based Donor Recruitment and Predonation Serologic Testing for COVID-19 Convalescent Plasma.
Joanna Balcerek, Evelin Trejo, Kendall Levine, Paul Couey, Zoe V. Kornberg, Camille Rogine, Charlotte Aimee Young, P. Jonathan Li, Brian R. Shy, Jordan E. Taylor, Sara...> ;American Journal of Clinical Pathology. 2021 Mar 15
16 citations
Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity.
Kara L. Lynch, Jeffrey D. Whitman, Noreen P Lacanienta, Erica W Beckerdite, Shannon A Kastner, Brian R. Shy, Gregory M. Goldgof, Andrew G. Levine, Sagar P. Bapat, Susa...> ;Clinical Infectious Diseases. 2020 Jul 14
110 citations
Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier.
Jonathan H. Esensten, Yannick D. Muller, Jeffrey A. Bluestone, Qizhi Tang> ;The Journal of Allergy and Clinical Immunology. 2018 Dec 1
479 citations
Reprogramming human T cell function and specificity with non-viral genome targeting
Theodore L. Roth, Cristina Puig-Saus, Ruby Yu, Eric Shifrut, Julia Carnevale, P. Jonathan Li, Joseph Hiatt, Justin Saco, Paige Krystofinski, Han Li, Victoria Tobin, Da...> ;Nature. 2018 Jul 11
40 citations
Engineering Therapeutic T Cells: From Synthetic Biology to Clinical Trials.
Jonathan H. Esensten, Jeffrey A. Bluestone, Wendell A. Lim> ;Annual Review of Pathology. 2017 Jan 30
483 citations
CD28 Costimulation: From Mechanism to Therapy
Jonathan H. Esensten, Ynes Helou, Gaurav Chopra, Arthur Weiss, Jeffrey A. Bluestone> ;Immunity. 2016 May 17
49 citations
Cdk8 deletion in the Apc(Min) murine tumour model represses EZH2 activity and accelerates tumourigenesis.
Mark McCleland, Tim M. Soukup, Scot D. Liu, Jonathan H. Esensten, Felipe De Sousa E Melo, Murat Yaylaoglu, Søren Warming, Merone Roose-Girma, Ron Firestein> ;The Journal of Pathology. 2015 Dec 1
35 citations
Circulating proteolytic signatures of chemotherapy-induced cell death in humans discovered by N-terminal labeling
Arun P. Wiita, Gerald W. Hsu, Chuanyi M. Lu, Jonathan H. Esensten, James A. Wells> ;Proceedings of the National Academy of Sciences of the United States of America. 2014 May 27
77 citations
CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell response
Marc Martinez-Llordella, Jonathan H. Esensten, Samantha L. Bailey-Bucktrout, Robert H. Lipsky, Ann M. Marini, Jun Chen, Mohamed Mughal, Mark P. Mattson, Dennis D. Taub...> ;The Journal of Experimental Medicine. 2013 Jul 29
96 citations
microRNA-17–92 Regulates IL-10 Production by Regulatory T Cells and Control of Experimental Autoimmune Encephalomyelitis
Dimitri de Kouchkovsky, Jonathan H. Esensten, Wendy Rosenthal, Malika M. Morar, Jeffrey A. Bluestone, Lukas T. Jeker> ;Journal of Immunology. 2013 Aug 15
298 citations
Intrinsic and extrinsic control of peripheral T‐cell tolerance by costimulatory molecules of the CD28/ B7 family
Hélène Bour-Jordan, Jonathan H. Esensten, Marc Martinez-Llordella, Cristina Penaranda, Melanie Stumpf, Jeffrey A. Bluestone> ;Immunological Reviews. 2011 May 1
321 citations
Plasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes
Stephanie McClymont, Amy L. Putnam, Michael R. Lee, Jonathan H. Esensten, Weihong Liu, Maigan A. Hulme, Ulrich Hoffmüller, Udo Baron, Sven Olek, Jeffrey A. Bluestone, ...> ;Journal of Immunology. 2011 Apr 1
88 citations
Regulatory T cells as therapeutic targets in rheumatoid arthritis.
Jonathan H. Esensten, David Wofsy, Jeffrey A. Bluestone> ;Nature Reviews. Rheumatology. 2009 Oct 1
58 citations
T-bet-Deficient NOD Mice Are Protected from Diabetes Due to Defects in Both T Cell and Innate Immune System Function
Jonathan H. Esensten, Michael R. Lee, Laurie H. Glimcher, Jeffrey A. Bluestone> ;Journal of Immunology. 2009 Jul 1
50 citations
NFAT5 binds to the TNF promoter distinctly from NFATp, c, 3 and 4, and activates TNF transcription during hypertonic stress alone
Jonathan H. Esensten, Alla V. Tsytsykova, Cristina López-Rodríguez, Filipa Ligeiro, Anjana Rao, Anne E. Goldfeld> ;Nucleic Acids Research. 2005 Jan 1
Join now to see all

Press Mentions

Building Robots to Expand Access to Cell TherapiesMay 12th, 2021

Hospital Affiliations

UCSF Medical CenterSan Francisco, California
Zuckerberg San Francisco General Hospital and Trauma CenterSan Francisco, California